Axa
MRK icon

Axa’s Merck MRK Stock Holding History

Axa’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.16M Sell
9,610
-957
-9% -$110K 0.45% 38
2025
Q4 		$1.11M Sell
10,567
-1,819
-15% -$171K 0.53% 43
2025
Q3 		$1.04M Sell
12,386
-1,293,946
-99% -$107M 0.52% 44
2025
Q2 		$103M Sell
1,306,332
-13,668
-1% -$1.09M 0.3% 66
2025
Q1 		$118M Buy
1,320,000
+9,053
+0.7% +$845K 0.39% 56
2024
Q4 		$130M Buy
1,310,947
+76,424
+6% +$7.88M 0.4% 51
2024
Q3 		$140M Buy
1,234,523
+119,871
+11% +$14.2M 0.42% 49
2024
Q2 		$138M Sell
1,114,652
-53,042
-5% -$6.83M 0.41% 46
2024
Q1 		$154M Sell
1,167,694
-136,922
-10% -$16.9M 0.46% 44
2023
Q4 		$142M Sell
1,304,616
-241,388
-16% -$25.1M 0.46% 44
2023
Q3 		$159M Sell
1,546,004
-172,109
-10% -$18.6M 0.56% 33
2023
Q2 		$198M Sell
1,718,113
-64,844
-4% -$7.36M 0.66% 24
2023
Q1 		$175M Sell
1,782,957
-400,302
-18% -$43.2M 0.6% 29
2022
Q4 		$229M Sell
2,183,259
-261,888
-11% -$26.8M 0.83% 13
2022
Q3 		$217M Buy
2,445,147
+30,184
+1% +$2.69M 0.85% 13
2022
Q2 		$215M Sell
2,414,963
-52,322
-2% -$4.64M 0.8% 14
2022
Q1 		$184M Buy
2,467,285
+22,803
+0.9% +$1.8M 0.52% 32
2021
Q4 		$167M Buy
2,444,482
+5,234
+0.2% +$417K 0.43% 44
2021
Q3 		$183M Sell
2,439,248
-112,249
-4% -$8.54M 0.51% 31
2021
Q2 		$198M Buy
2,551,497
+51,809
+2% +$3.85M 0.56% 27
2021
Q1 		$184M Buy
2,499,688
+297,390
+14% +$21.9M 0.56% 26
2020
Q4 		$172M Buy
2,202,298
+114,943
+6% +$8.79M 0.54% 32
2020
Q3 		$165M Sell
2,087,355
-163,007
-7% -$12.8M 0.6% 26
2020
Q2 		$166M Sell
2,250,362
-19,447
-0.9% -$1.46M 0.65% 23
2020
Q1 		$167M Buy
2,269,809
+412,527
+22% +$32.4M 0.83% 15
2019
Q4 		$161M Buy
1,857,282
+110,334
+6% +$9.06M 0.66% 22
2019
Q3 		$140M Sell
1,746,948
-60,654
-3% -$4.86M 0.56% 25
2019
Q2 		$145M Buy
1,807,602
+92,863
+5% +$7.11M 0.56% 25
2019
Q1 		$136M Sell
1,714,739
-177,594
-9% -$13.3M 0.53% 29
2018
Q4 		$138M Sell
1,892,333
-338,925
-15% -$23.9M 0.6% 22
2018
Q3 		$151M Sell
2,231,258
-924,362
-29% -$58.9M 0.55% 32
2018
Q2 		$183M Buy
3,155,620
+137,797
+5% +$7.77M 0.7% 19
2018
Q1 		$157M Buy
3,017,823
+149,163
+5% +$8.06M 0.63% 20
2017
Q4 		$154M Buy
2,868,660
+1,541,507
+116% +$85.5M 0.6% 25
2017
Q3 		$81.1M Buy
1,327,153
+5,227
+0.4% +$317K 0.35% 68
2017
Q2 		$80.8M Sell
1,321,926
-118,282
-8% -$7.2M 0.37% 65
2017
Q1 		$87.3M Sell
1,440,208
-219,215
-13% -$13.3M 0.39% 56
2016
Q4 		$93.2M Sell
1,659,423
-122,546
-7% -$7.17M 0.44% 52
2016
Q3 		$106M Sell
1,781,969
-154,622
-8% -$9.04M 0.47% 47
2016
Q2 		$106M Sell
1,936,591
-992,413
-34% -$52.8M 0.47% 43
2016
Q1 		$148M Sell
2,929,004
-1,242,802
-30% -$60.9M 0.66% 26
2015
Q4 		$210M Sell
4,171,806
-4,059,913
-49% -$205M 0.92% 14
2015
Q3 		$388M Buy
8,231,719
+3,201,121
+64% +$170M 1.59% 5
2015
Q2 		$273M Buy
5,030,598
+454,197
+10% +$25.5M 1.09% 9
2015
Q1 		$251M Buy
4,576,401
+658,226
+17% +$37.3M 1.03% 9
2014
Q4 		$212M Buy
3,918,175
+329,951
+9% +$18.4M 0.85% 13
2014
Q3 		$203M Sell
3,588,224
-396,908
-10% -$22.3M 0.87% 11
2014
Q2 		$220M Buy
3,985,132
+236,228
+6% +$12.9M 0.92% 12
2014
Q1 		$203M Buy
3,748,904
+1,548,373
+70% +$80.2M 0.88% 17
2013
Q4 		$105M Sell
2,200,531
-160,705
-7% -$7.35M 0.47% 48
2013
Q3 		$107M Buy
2,361,236
+136,104
+6% +$6.21M 0.53% 41
2013
Q2 		$98.6M Buy
+2,225,132
New +$99.4M 0.52% 43

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Axa's MRK Position: Q1 2026 in Review

Axa reduced its Merck (MRK) stake by 9.1% in Q1 2026, selling an estimated $110K and leaving 9,610 shares worth $1.16M. The position accounts for 0.45% of the portfolio, ranked #38.

Axa first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $388M in Q3 2015. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Axa held 9,610 shares of Merck worth $1.16M as of Q1 2026.
  • Axa sold 957 Merck shares in Q1 2026, an estimated $110K.
  • Merck made up 0.45% of Axa's portfolio in Q1 2026, its #38 holding.
  • Axa first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Axa's Merck position peaked at $388M in Q3 2015.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Axa's 13F filing for Q1 2026, filed 15 May 2026.